Tsila Zukerman

37PUBLICATIONS
160CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Genetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|May 27, 2026
Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World Study.

|Feb 13, 2026
Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS Onset.

Hazim Khatib, Amit Parizat, Jabour Halloun

|Oct 22, 2025
CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia.

Ofrat Beyar-Katz, Ohad Benjamini, Julio Delgado

|Sep 15, 2025
Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm.

Michal Nordkin, Nashwa Fadaos, Ronit Leiba

|Jun 27, 2025
CCR5 predicts neurotoxicity in CAR-T-cell therapy.

Ayal Rozenberg, Shahar Shelly, Raz Winer

|May 28, 2025
Progressive Multifocal Leukoencephalopathy (PML) after hematopoietic cell transplantation (HCT): a retrospective study of Infectious Diseases Working Party (IDWP) of the EBMT.

Jarosław Dybko, Wojciech Szlasa, Lidia Gil

Pageof 7

Frequent Collaborators

5 joint publications

Jaime Sanz

4 joint publications

Nicolaus Kröger

4 joint publications

Mohamad Mohty

4 joint publications

Shimrit Ringelstein-Harlev